City

Paris (1)

Phoenix (1)

Condition

Inclusion Body Myositis (IBM) (2)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 2/phase 3 (1)

Sponsor

Institut National de la Sante Et de la Recherche Medicale, France (1)

Phoenix Neurological Associates, LTD (1)

Collaborator

Intervention

natalizumab (1)

placebo (1)

rapamycin (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

inclusion body myositis (ibm)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Inclusion Body Myositis (IBM) Trial in Paris (Rapamycin, Placebo)

Completed

Inclusion Body Myositis (IBM)

Rapamycin
Placebo

Paris, France

CIC Paris Est _Hôpital Pitié Salpêtrière

Jan 8, 2019

Inclusion Body Myositis (IBM) Trial in Phoenix (Natalizumab)

Unknown status

Inclusion Body Myositis (IBM)

Natalizumab

Phoenix, Arizona

Phoenix Neurological Insitutute

Feb 8, 2017